Related references
Note: Only part of the references are listed.Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
Tomáš Šimůnek et al.
Pharmacological Reports (2014)
Adiponectin protects against doxorubicin-induced cardiomyopathy by anti-apoptotic effects through AMPK up-regulation
Masanori Konishi et al.
CARDIOVASCULAR RESEARCH (2011)
Regulation of reactive oxygen species by p53: implications for nitric oxide-mediated apoptosis
Daniel A. Popowich et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Glutamine regulation of doxorubicin accumulation in hearts versus tumors in experimental rats
Valentina K. Todorova et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes
Partha Mukhopadhyay et al.
CARDIOVASCULAR RESEARCH (2010)
Doxorubicin In Vivo Rapidly Alters Expression and Translation of Myocardial Electron Transport Chain Genes, Leads to ATP Loss and Caspase 3 Activation
Amy V. Pointon et al.
PLOS ONE (2010)
Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro
Partha Mukhopadhyay et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Acute Doxorubicin Cardiotoxicity Is Associated With p53-Induced Inhibition of the Mammalian Target of Rapamycin Pathway
Wuqiang Zhu et al.
CIRCULATION (2009)
A splice variant of cyclin D2 regulates cardiomyocyte cell cycle through a novel protein aggregation pathway
Qian Sun et al.
JOURNAL OF CELL SCIENCE (2009)
Alteration of Matrix Metalloproteinases in Selective Left Ventricular Adriamycin-Induced Cardiomyopathy in the Pig
Andreas Goetzenich et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2009)
Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity
Masashi Yoshida et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Murine double minute 2: p53-independent roads lead to genome instability or death
Alyssa Bouska et al.
TRENDS IN BIOCHEMICAL SCIENCES (2009)
Von Willebrand factor in cardiovascular disease focus on acute coronary syndromes
Alexander O. Spiel et al.
CIRCULATION (2008)
Quantification of cardiac fibrosis by colour-subtractive computer-assisted image analysis
Gerard J. Gaspard et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2008)
Pharmacological inhibition of CB1 cannabinoid raceptor protects against doxorubicin-induced cardiotoxicity
Partha Mukhopadhyay et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Mitochondrial and nuclear p53 localization in cardiomyocytes: Redox modulation by doxorubicin (adriamycin)?
Ramaneeya Nithipongvanitch et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
Evidence for p53 as guardian of the cardiomyocyte mitochondrial genome following acute adriamycin treatment
Rarnaneeya Nithipongvanitch et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2007)
Doxorubicin-induccd cardiomyopathy from the cardiotoxic mechanisms to management
Genzou Takemura et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2007)
Cytoskeletal networks and the regulation of cardiac contractility: microtubules, hypertrophy, and cardiac dysfunction
George Cooper
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Two distinct signaling pathways regulate peroxynitrite-induced apoptosis in PC12 cells
J. J. Shacka et al.
CELL DEATH AND DIFFERENTIATION (2006)
Increased cardiac mRNA expression of matrix metalloproteinase-1 (MMP-1) and its inhibitor (TIMP-1) in DCM patients
F Picard et al.
CLINICAL RESEARCH IN CARDIOLOGY (2006)
Matrix metalloproteinase-2 and-9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase
P Spallarossa et al.
CARDIOVASCULAR RESEARCH (2006)
Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy
LH Li et al.
CIRCULATION (2006)
The distribution of the anticancer drug doxorubicin in relation to blood vessels in solid tumors
AJ Primeau et al.
CLINICAL CANCER RESEARCH (2005)
Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies
KA Wouters et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
The antioxidant function of the p53 tumor suppressor
AA Sablina et al.
NATURE MEDICINE (2005)
Manganese superoxide dismutase and inducible nitric oxide synthase modify early oxidative events in acute Adriamycin-induced mitochondrial toxicity
L Chaiswing et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice
Y Shizukuda et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2005)
Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice
KBS Pasumarthi et al.
CIRCULATION RESEARCH (2005)
Pifithrin-α protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice
XW Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Anthracyclines induce calpain-dependent titin proteolysis and necrosis in cardiomyocytes
CC Lim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Diversity of structures and properties among catalases
P Chelikani et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Evaluating the role of dexrazoxane as a cardioprotectant in cancer patients receiving anthracyclines
P Pouillart
CANCER TREATMENT REVIEWS (2004)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis
WP Tsang et al.
LIFE SCIENCES (2003)
Alterations in myocardial cytoskeletal and regulatory protein expression following a single doxorubicin injection
TV Dudnakova et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2003)
Resistance of p53 knockout cells to doxorubicin is related to reduced formation of DNA strand breaks rather than impaired apoptotic signaling
TR Dunkern et al.
DNA REPAIR (2003)
Phenotypic consequences of beta(1)-tubulin expression and MAP4 decoration of microtubules in adult cardiocytes
M Takahashi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis
PS Green et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
Doxorubicin-induced apoptosis: Implications in cardiotoxicity
B Kalyanaraman et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2002)
Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism
E Lorenzo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer
J Jonkers et al.
NATURE GENETICS (2001)
Anticancer drugs induce necrosis of human endothelial cells involving both oncosis and apoptosis
A Mailloux et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2001)
p53 is associated with cellular microtubules and is transported to the nucleus by dynein
P Giannakakou et al.
NATURE CELL BIOLOGY (2000)
Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death
J Shirani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Share Paper
